The kininogen gene family in obstructive uropathy

Seminars in Nephrology

Volumn 18, Issue 6, 1998, Pages 633-640

  El Dahr, Samir S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KININOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DIURESIS; DOG; GENE EXPRESSION; KALLIKREIN KININ SYSTEM; KIDNEY FAILURE; KIDNEY FUNCTION; NATRIURESIS; NEPHRON; NONHUMAN; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; GENE EXPRESSION REGULATION; HEMODYNAMIC PROCESSES; HUMANS; KALLIKREIN-KININ SYSTEM; KININOGENS; KININS; MOLECULAR SEQUENCE DATA; URETERAL OBSTRUCTION;

EID: 0031733975     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Klahr S, Buerkert J, Pukerson ML: The kidney in obstructive uropathy. Contr Nephrol 7:220-249, 1977
2. Bhoola KD, Figueroa CD, Worthy K: Bioregulation of kinins: Kallikreins, kininogens and kinases. Pharmacol Rev 44:1-80, 1992
3. Ni AG, Chao L, Chao J: Transcription factor nuclear factor kappa B regulates the inducible expression of the human B-l receptor gene in inflammation. J Biol Chem 273:2784-2791, 1998
4. Pruneau D, Belichard P: Induction of bradykinin B, receptor-mediated relaxation in the isolated rabbit carotid artery. Eur J Pharmacol 239:63-67, 1993
5. Skidgel RA: Bradykinin-degrading enzymes: Structure, function, distribution, and potential roles in cardiovascular pharmacology. J Cardiovasc Pharmacol 20: S4-S9, 1992 (suppl 9)
6. Deddish PA, Wang LX, Jackman HL, et al: Singledomain angiotensin I converting enzyme (kininase II): Char-acterization and properties. J Pharmacol Exp Ther 279:1582-1589, 1996
7. Figueroa CD, Caorsi I, Subiabre J, Vio CP: Immunoreactive kallikrein localization in the rat kidney: An immunoelectron microscopic study. J Histochem Cytochem 32:112-121, 1984
8. Figueroa CD, Maciver AG, MacKenzie JC, Bhoola KD: Localization of immunoreactive kininogen and tissue kallikrein in the human nephron. Histochemistry 89:432-442, 1988
9. 2, and cyclic guanosine 3′5′-monophosphate. Effects of altered sodium intake. Hypertension 23:1068-1070, 1994
10. Ranker ML: Bradykinin action on the efflux of luminal Na in the rat nephron. J Pharmacol Exp Ther 214:119-123, 1980
11. Roman RJ, Kaldunski ML, Scicli AG, Carretero OA: Influence of kinins and angiotensin II on the regulation of papillary blood flow. Am J Physiol 255:F690-F698, 1988
12. Fenoy FJ, Roman RJ: Effect of kinin receptor antagonists on renal hemodynamic and natriuretic responses to volume expansion. Am J Physiol 263:R1136-R1140, 1992
13. Mattson DL, Cowley AW: Kinin actions on renal papillary blood flow and sodium excretion. Hypertension 21:961-965, 1993
14. 2-receptor antagonist, on renal function in conscious normotensive rats. Br J Pharmacol 106:380-386, 1992
15. Siragy HM: Evidence that intrarenal bradykinin plays a role in regulation of renal function. Am J Physiol 265:E648-E654, 1993
16. Vio CP, Figueroa CD, Caorsi I: Anatomical relationship between kallikrein containing tubules and the juxtaglomerular apparatus in the human kidney. Am J Hypertens 1:269-271, 1988
17. Baylis C, Deen WM, Myers BD, Brenner BM: Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol 230:1148-1158, 1976
18. Kon V, Fogo A, Ichikawa I: Bradykinin causes selective efferent vasodilation during angiotensin I converting enzyme inhibition. Kidney Int 44:545-550, 1993
19. Fuller PJ, Clements JA, Nikolaidis, et al: Ezpression of the renal kallikrein gene in mineralocorticoid treated and genetically hypertensive rats. J Hypertens 4:427-433, 1986
20. Miller DH, Chao J, Margolius HS: Tissue kallikrein synthesis and its modification by testosterone or low dietary sodium. Biochem J 218:37-43, 1984
21. Bascands JL, Girolami JP, Pecher C, et al: Compared effects of a low and a high sodium diet on the renal and urinary concentration and activity of kallikrein in normal rats. J Hypertens 5:311-315, 1987
22. 2 receptors. Am J Physiol 270: F425-F431, 1996
23. Madeddu P, Glorioso N, Maioli M, et al: Regulation of rat renal kallikrein expression by estrogen and progesterone. J Hypertens 9: S244-S245, 1991 (suppl 6)
24. El-Dahr SS, Yosipiv IV: Developmentally regulated kallikrein enzymatic activity and gene transcription rate in maturing rat kidneys. Am J Physiol 265:F146-F150, 1993
25. El-Dahr SS, Chao J: Spatial and temporal expression of kallikrein and its mRNA during nephron maturation. Am J Physiol 262:F705-F711, 1992
26. Kakizuka A, Kitamura N, Nakanishi S: Localization of DNA sequences governing alternative mRNA production of rat kininogen genes. J Biol Chem 263:3884-3892, 1988
27. Kakizuka A, Ingi T, Murai T, Nakanishi S: A set of Ui snRNA complementary sequences involved in governing alternative RNA splicing of the kininogen genes. J Biol Chem 265:1-7, 1990
28. Okamato H, Greenbaum LM: Isolation and structure of T-kinin. Biochem Biophys Res Commun 112:701-708, 1983
29. Furuto Kato S, Matsumoto A, Kitamura N, Nakanishi S: Primary structures of the mRNAs encoding the rat precursors for bradykinin and T-kinin. J Biol Chem 260:12504-12509, 1985
30. 1-protein (thiostatin) and kininogen in the rat. J Biol Chem 262:9298-9308, 1987
31. Chao J, Swain C, Chao S, et al: Tissue distribution and kininogen gene expression after acute phase inflammation. Biochem Biophys Acta 964:329-339, 1988
32. El-Dahr SS, Dipp S: Differential effects of ureteral obstruction on rat kininogen gene family. J Am Soc Nephrol 5:102-109, 1994
33. 2 bradykinin receptor. Proc Natl Acad Sci USA 88: 7724-7728, 1995
34. 2 receptor gene. Biochim Biophys Acta 1219: 171-174, 1994
35. 2 receptor. Genomics 23: 362-369, 1994
36. Powell SJ, Slynn G, Thomas C, et al: Human bradykinin B2 receptor: Nucleotide sequence analysis and assignment to chromosome 14. Genomics 15: 435-438, 1993
37. 2 receptor. Gene 149: 283-288, 1994
38. 2 bradykinin receptors in NG-108-15 cells: cDNA cloning and functional expression. Biochem Biophys Res Commun 200: 634-641, 1994
39. 2 receptor gene. Evidence for alternative splicing. J Biol Chem 269:26920-26925, 1994
40. 2 receptors in the rat kidney: Implications for segmental nephron maturation. Kidney Int 51: 739-749, 1997
41. Hornig B, Kohler C, Drexler H: Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 95:1115-1118, 1997
42. Majima M, Mizogami S, Kuribayashi Y, et al: Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats. Hypertension 24:111-119, 1994
43. 2-receptors enhances the slow vasopressor response to angiotensin II. Hypertension 23: 646-652, 1994
44. Wang J, Xiong W, Yang Z, et al: Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 23:236-243, 1994
45. 2 receptor knockout mice. Biochim Biophys Res Commun 224: 625-630, 1996
46. 2-receptor gene. Circulation 96:3570-3578, 1997
47. Awazu M, Barakat AY, Chevalier RL, Ichikawa I: The cause of uremia in obstructed kidneys. J Pediatr 114:179-186, 1989
48. Vaughan ED Jr, Sorensson EJ, Gillenwater JY: The renal hemodynamic response to chronic unilateral complete ureteral occlusion. Invest Urol 8:78-90, 1970
49. Yarger WE, Schocken DD, Harris RH: Obstructive nephropathy in the rat. Possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function. J Clin Invest 65:400-412, 1980
50. Reyes AA, Leflcowith J, Pippin J, Klahr S: The role of the 5-lipoxygenase pathway in obstructive nephropathy. Kidney Int 41: 100-106, 1992
51. Reyes AA, Robertson G, Klahr S: Role of antidiuretic hormone in obstructive nephropathy. Proc Soc Exp Biol Med197:49-55, 1991
52. Reyes AA, Klahr S: Renal function after release of ureteral obstruction: Role of endothelin and the renal artery endothelium. Kidney Int 42:632-638, 1992
53. Chevalier RL, Peach MJ: Hemodynamic effects of enalapril on neonatal chronic partial ureteral obstruction. Kidney Int 28:891-898, 1985
54. El-Dahr SS, Gomez RA, Peach MJ, et al: In situ localization of renin and its mRNA in neonatal ureteral obstruction. Am J Physiol 258:F854-F862, 1990
55. El-Dahr SS, Gomez RA, Gray MS, et al: Renal nerves modulate renin gene expression in the developing kidney with ureteral obstruction. J Clin Invest 87:800-810, 1991
56. Kon Y, Takahashi S, Fukamizu A, et al: Morphological and northern blot analysis of juxtaglomerular cells in experimental hydronephrotic kidneys. Anat Rec 232:393-400, 1992
57. Reyes AA, Martin D, Settle S, Klahr S: EDRF role in renal function and blood pressure of normal rats and rats with obstructive uropathy. Kidney Int 41:403-413, 1992
58. Chevalier RL, Thornhill BA, Gomez RA: EDRF modulates renal hemodynamics during unilateral ureteral obstruction in the rat. Kidney Int 42:400-406, 1992
59. Yarger WE, Newman WJ, Klotman PE: Renal effects of aprotinin after 24 hours of unilateral ureteral obstruction. Am J Physiol 253:F1006-F1014, 1987
60. Hock FJ, Wirth K, Albus U, et al: Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 102:769-773, 1991
61. Wirth K, Hock FJ, Albus U, et al: Hoe 140 a new potent and long acting bradykinin-antagonist: In vivo studies. BrJ Pharmacol 102:774-777, 1991
62. Lembeck F, Griesbacher T, Eckhardt M, et al: New, long-acting, potent bradykinin antagonists. Br J Pharmacol 102:297-304, 1991
63. 2 receptor antagonist. An in vitro study. Hypertension 29:951-956, 1997
64. 2 receptor antagonist, FR 173657. Br J Pharmacol 120: 617-624, 1997
65. Lawton W, O'Connor G, Nelson J, Fitz A: Urinary kallikrein in postobstructive diuresis. Invest Urol 17:320-323, 1980
66. El-Dahr SS, Gee J, Dipp S, et al: Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy. Am J Physiol 264:F874-F881,1993
67. Storch S, Saggi S, Megyesi J, et al: Ureteral obstruction decreases renal preproepidermal growth factor and Tamm-Horsfall expression. Kidney Int 42:89-94, 1992
68. El-Dahr SS, Dipp S: Differential effects of ureteral obstruction on rat kininogen gene family. J Am Soc Nephrol 5:102-109, 1994
69. El-Dahr SS, Dipp S, Yosipiv IV, et al: Activation of kininogen expression during distal nephron differentiation. Am J Physiol 275:F173-F182, 1998
70. Xiong W, Chen L-M, Chao J: Purification and characterization of a kallikrein-like T-kininogenase. J Biol Chem 265:2822-2827, 1990
71. Sueyoshi T, Enjyoji K, Shimada T, et al: A new function of kininogens as thiol-proteinase inhibitors: Inhibition of papain and cathepsins B, H and L by bovine, rat and human plasma kininogens. FEBS Lett 182:193-195, 1985
72. Chen H-M, Liao WSL: Differential acute-phase response of rat kininogen genes involves type I and type II interleukin-6 response elements. J Biol Chem 268:2531125319, 1993
73. Chen H-M, Liao WSL: Molecular analysis of the differential hepatic expression of rat kininogen gene family. Mol Cell Biol 13:6766-6777, 1993
74. Desrivieres S, Lu H, Peyri N, et al: Activation of the 92 kDa type IV collagenase by tissue kallikrein. J Cell Physiol 157:587-593, 1993